QUANTRO Therapeutics GmbH | Finanzwire

Basculer en Français

9473	Companies
185399	Keywords
117755	Articles
99281	Press releases

Headlines Articles Press releases QUANTRO Therapeutics GmbH

Home
Companies
QUANTRO Therapeutics GmbH

BRIEF

published on 10/14/2025 at 10:05, 1 month 21 days ago

QUANTRO Therapeutics Extends Cancer Collaboration with Boehringer Ingelheim

Cancer Treatment Collaboration Boehringer Ingelheim QUANTRO Therapeutics Transcriptomics
PRESS RELEASE

published on 10/14/2025 at 10:00, 1 month 21 days ago

QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim to address high unmet needs in cancer patients
QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim to develop innovative cancer treatments, targeting transcription factors. Collaboration aims to address high unmet needs in cancer patients

Collaboration Boehringer Ingelheim QUANTRO Therapeutics Transcription Factors Cancer Patients
BRIEF

published on 01/07/2025 at 14:35, 10 months 28 days ago

QUANTRO Therapeutics Reaches Milestone in Transcriptomic Drug Discovery

Biotech Showcase QUANTRO Therapeutics Transcriptomic Drug Discovery Multiplex-Screening QUANTROseq® Platform
PRESS RELEASE

published on 01/07/2025 at 14:30, 10 months 28 days ago

QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening
QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening. CEO Dr. Michael Bauer to attend industry events in San Francisco

Biotech Showcase QUANTRO Therapeutics Transcriptomic Drug Discovery Multiplex-Screening WuXi Global Forum
BRIEF

published on 10/24/2024 at 09:35, 1 year 1 month ago

QUANTRO Therapeutics and IMP Form Research Alliance for Drug Discovery

Drug Discovery Cancer Therapy QUANTRO Therapeutics IMP Collaboration Transcription Factor
PRESS RELEASE

published on 10/24/2024 at 09:30, 1 year 1 month ago

QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery
QUANTRO Therapeutics partners with IMP to advance transcriptomic drug discovery. Strategic collaboration to explore transcription factors' functions for cancer therapies

QUANTRO Therapeutics Transcription Factors IMP Transcriptomic Drug Discovery Cancer Therapies
BRIEF

published on 08/06/2024 at 10:05, 1 year 3 months ago

QUANTRO Therapeutics Secures Key Austrian Research Grant to Advance Platform Development

Drug Discovery QUANTRO Therapeutics FFG Grant Transcriptomic Platform Multiplexing
PRESS RELEASE

published on 08/06/2024 at 10:00, 1 year 3 months ago

QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform
QUANTRO Therapeutics secures Austrian research grant to accelerate cutting-edge platform development, enabling multiplex target screening in drug discovery

Drug Discovery QUANTRO Therapeutics Austrian Research Grant Transcriptomic Discovery Platform Multiplexing Capabilities
BRIEF

published on 06/04/2024 at 23:12, 1 year 6 months ago

QUANTRO Therapeutics Reaches Milestone in Collaboration with Boehringer Ingelheim

Cancer Treatments R&D Collaboration Boehringer Ingelheim QUANTRO Therapeutics Transcription Factors
PRESS RELEASE

published on 06/04/2024 at 23:07, 1 year 6 months ago

QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments
QUANTRO Therapeutics achieves key milestone in collaboration with Boehringer Ingelheim for first-in-class cancer treatments using proprietary technology

Cancer Treatments Boehringer Ingelheim QUANTRO Therapeutics Transcription Factors R&D Program

Accesswire

Published on 12/05/2025 at 02:35, 6 hours 16 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 21 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 51 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 46 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 51 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:30, 21 minutes ago

Dahua Technology Celebrates Pro Challenge 2025 to Deepen Global Installer Ecosystem Collaboration
Published on 12/05/2025 at 08:30, 21 minutes ago

Premier Miton Global Renewables Trust PLC - Suspension
Published on 12/05/2025 at 08:05, 46 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 50 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 50 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025

Les Echos

Published on 12/05/2025 at 08:45, 6 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 14 hours 51 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 6 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 7 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE